Zika N-Terminal Envelope Protein

<strong>Zika N-Terminal Envelope Protein</strong>_x000D_ <strong>Catalog number:</strong> B2012329_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 100 ug_x000D_ <strong>Molecular Weight or Concentration:</strong> na_x000D_ <strong>Supplied as:</strong> Solution_x000D_ <strong>Applications:</strong> molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> -20°C_x000D_ <strong>Keywords:</strong> Zika Envelope N protein_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1: Giraldo MI, Xia H, Aguilera-Aguirre L, Hage A, van Tol S, Shan C, Xie X, Sturdevant GL, Robertson SJ, McNally KL, Meade-White K, Azar SR, Rossi SL, Maury W, Woodson M, Ramage H, Johnson JR, Krogan NJ, Morais MC, Best SM, Shi PY, Rajsbaum R. Envelope protein ubiquitination drives entry and pathogenesis of Zika virus Nature. 2020 Sep;585(7825):414-419._x000D_ 2: Dai L, Wang Q, Song H, Gao GF. Zika Virus Envelope Protein and Antibody Complexes Subcell Biochem. 2018;88:147-168._x000D_ 3: Elfiky AA, Ibrahim IM. Zika virus envelope - heat shock protein A5 (GRP78) binding site prediction J Biomol Struct Dyn. 2021 Sep;39(14):5248-5260._x000D_ 4: Yang C, Gong R, de Val N. Development of Neutralizing Antibodies against Zika Virus Based on Its Envelope Protein Structure Virol Sin. 2019 Apr;34(2):168-174._x000D_ 5: Carbaugh DL, Baric RS, Lazear HM. Envelope Protein Glycosylation Mediates Zika Virus Pathogenesis J Virol. 2019 May 29;93(12):e00113-19._x000D_ 6: Wang Y, Li Q, Hu D, Gao D, Wang W, Wu K, Wu J. USP38 Inhibits Zika Virus Infection by Removing Envelope Protein Ubiquitination Viruses. 2021 Oct 8;13(10):2029._x000D_ 7: Hu D, Wang Y, Li A, Li Q, Wu C, Shereen MA, Huang S, Wu K, Zhu Y, Wang W, Wu J. LAMR1 restricts Zika virus infection by attenuating the envelope protein ubiquitination Virulence. 2021 Dec;12(1):1795-1807._x000D_ 8: Gunawardana SA, Shaw RH. Cross-reactive dengue virus-derived monoclonal antibodies to Zika virus envelope protein: Panacea or Pandora's box? BMC Infect Dis. 2018 Dec 10;18(1):641._x000D_ 9: Pindi C, Chirasani VR, Senapati S. Identifying crucial E-protein residues responsible for unusual stability of Zika virus envelope Biophys J. 2021 Sep 21;120(18):4041-4054._x000D_ <a href="https://pubmed.ncbi.nlm.nih.gov/34019939">10: Kim YC, Nettleship JE, García-Larragoiti N, Mar MA, Mondragón-García AL, Ríos-Valencia J, Figueroa-Aguilar G, Viveros-Sandoval ME, Owens RJ, Reyes-Sandoval A. Temperature-dependent secretion of Zika virus envelope and non-structural protein 1 in mammalian cells for clinical applications J Virol Methods. 2021 Aug;294:114175. </a>_x000D_ _x000D_ <strong>Products Related to Zika N-Terminal Envelope Protein can be found at</strong> <a href="https://moleculardepot.com/product-category/Proteins/"> Proteins</a>